Quipt Home Medical Corp - Ordinary Shares New Forecast, price target & analysts
Quipt Home Medical Corp - Ordinary Shares New Target price 2025 - Analyst rating & recommendation
Quipt Home Medical Corp - Ordinary Shares New Classifications & Recommendation:
Quipt Home Medical Corp - Ordinary Shares New Price Target
| Target Price | $6.45 |
| Price | $2.67 |
| Potential |
141.72%
register free of charge
|
| Number of Estimates | 5 |
|
5 Analysts have issued a price target Quipt Home Medical Corp - Ordinary Shares New 2026 .
The average Quipt Home Medical Corp - Ordinary Shares New target price is $6.45.
This is
141.72%
register free of charge
$12.00
349.44%
register free of charge
$4.00
49.81%
register free of charge
|
|
| A rating was issued by 5 analysts: 5 Analysts recommend Quipt Home Medical Corp - Ordinary Shares New to buy, 0 to hold and 0 to sell. | |
| Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis. | |
|
Analyst Estimates: Analysts believe that the Quipt Home Medical Corp - Ordinary Shares New stock has an average upside potential 2026 of
141.72%
register free of charge
|
Sales and Margin forecast 2025, 2026 & 2027
| Sep '24 |
2025 Estimates |
|
|---|---|---|
| Revenue Million $ | 245.92 | 250.74 |
| 16.18% | 1.96% | |
| EBITDA Margin | 19.56% | 23.05% |
| 1.17% | 17.82% |
5 Analysts have issued a sales forecast Quipt Home Medical Corp - Ordinary Shares New 2025 . The average Quipt Home Medical Corp - Ordinary Shares New sales estimate is
This results in the following potential growth metrics:
5 Analysts have issued an Quipt Home Medical Corp - Ordinary Shares New EBITDA forecast 2025. The average Quipt Home Medical Corp - Ordinary Shares New EBITDA estimate is
This results in the following potential growth metrics and future EBITDA Margins:
Earnings per share, P/E ratio and EV/sales Estimates 2025, 2026 & 2027
| Sep '24 |
2025 Estimates |
|
|---|---|---|
| EV/Sales | 0.80 |
Based on analysts' sales estimates for 2025, the Quipt Home Medical Corp - Ordinary Shares New stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of
This results in the following potential growth metrics and future valuations:
Quipt Home Medical Corp - Ordinary Shares New...
Current Quipt Home Medical Corp - Ordinary Shares New Upgrades & Downgrades Beta
| Analyst | Rating | Action | Date |
|---|---|---|---|
| THE BENCHMARK COMPANY LLC | Locked ➜ Locked | Locked | Dec 19 2024 |
| CANACCORD GENUITY | Locked ➜ Locked | Locked | Dec 17 2024 |
| STIFEL CANADA | Locked ➜ Locked | Locked | Dec 16 2024 |
| Analyst Rating | Date |
|---|---|
|
Locked
THE BENCHMARK COMPANY LLC: Locked ➜ Locked
|
Dec 19 2024 |
|
Locked
CANACCORD GENUITY: Locked ➜ Locked
|
Dec 17 2024 |
|
Locked
STIFEL CANADA: Locked ➜ Locked
|
Dec 16 2024 |
Discover more stocks with a high price target
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.
